PASH (Pseudoangiomatous Stromal Hyperplasia): Understanding This Rare Breast Disorder
Updated: Nov 11
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What Is PASH?
Pseudoangiomatous stromal hyperplasia (PASH) is a rare, noncancerous breast condition in which abnormal collagen-filled growths form in one or both breasts [1]. It typically affects premenopausal women and does not increase breast cancer risk [1]. It is often found on routine mammograms [1]. A core needle biopsy is needed to rule out cancer, and treatment ranges from monitoring to surgical removal [1].
What the research says
PASH does not appear to raise cancer risk. In 185 patients with PASH on breast biopsy followed for a median of 6.2 years, later atypia or cancer was uncommon (5.4%), and the authors concluded PASH does not appear to increase cancer risk (Koshy et al., Histopathology, 2026) [2].
Ultrasound features can help with diagnosis. In 29 patients, 41.4% of PASH lesions showed linear or cystic dark areas on ultrasound, and contrast-enhanced ultrasound improved diagnostic specificity from 35.7% to 64.3% (Li et al., Breast J, 2025) [3].
What is PASH (pseudoangiomatous stromal hyperplasia)?
Pseudoangiomatous stromal hyperplasia is a benign condition involving the overgrowth of stromal tissue in the breast. The name, while complex, describes the microscopic appearance of the tissue, which mimics blood vessels (pseudoangiomatous) but is actually composed of collagen and stromal cells.

What are the symptoms and signs of PASH?
PASH may not present any outward symptoms, and many individuals are unaware they have the condition until it is detected during medical imaging. However, when symptoms do occur, they are typically localized to the breast tissue.
Common signs include:
Breast Enlargement: One breast may become significantly larger than the other [1], affecting bra fit or clothing.
Palpable Lumps: A firm, painless mass that can be felt during a breast self-exam [1].
Incidental Discovery: Detection during a routine mammogram or a biopsy performed for an unrelated reason [1].
Causes and Hormonal Links
The exact cause of pseudoangiomatous stromal hyperplasia remains unclear [1], but medical research suggests a strong connection to hormonal fluctuations. High levels of estrogen and progesterone are believed to be the primary contributors to the development of these growths.
Potential Risk Factors:
Premenopausal Status: The condition is most frequently diagnosed in women who have not yet reached menopause [1].
Gynecomastia: Males with enlarged breast tissue (gynecomastia) may occasionally develop PASH [1], likely due to elevated estrogen levels.
Hormonal Sensitivity: The stromal tissue in the breast may overreact to normal or elevated circulating hormones.

How is PASH diagnosed with a core needle biopsy?
A core needle biopsy is the only definitive method for diagnosing PASH [1]. Because the condition can mimic other breast disorders on imaging, a tissue sample is required for microscopic examination.
Procedure: A healthcare provider numbs the area with local anesthetic and uses a hollow needle to remove a tissue sample [1].
Pathology: A pathologist examines the sample to confirm the presence of PASH and ensure no malignant cells are present [1].
Differential Diagnosis: The biopsy helps distinguish PASH from breast cancer or other benign disorders like fibroadenomas.
How is PASH managed and treated?
Treatment for PASH is highly individualized and depends on the size of the growth, the presence of symptoms, and patient preference.

What is living with PASH like?
A PASH diagnosis can be emotionally taxing, even when the growth is confirmed to be benign [1]. Maintaining overall breast health and managing the psychological impact are important aspects of care.
Self-Care Recommendations:
Weight Management: Maintaining a healthy BMI can help manage overall breast cancer risk factors [1].
Physical Activity: Regular exercise is associated with lower risks of various breast disorders.
Alcohol Moderation: Reducing alcohol intake is a key step in protecting breast health [1].
Breast Self-Exams: Monthly exams help you stay familiar with your body and notice changes early [1].
Conclusion
While the name "pseudoangiomatous stromal hyperplasia" may sound intimidating, PASH is a noncancerous condition that does not elevate your risk for breast cancer. Whether managed through careful monitoring or surgical removal, the prognosis for PASH is excellent. Open communication with your healthcare team is essential for navigating the diagnosis and choosing the right management plan for your needs.
Frequently Asked Questions
1. Is PASH a form of breast cancer? No. PASH is a benign (noncancerous) growth and is not a symptom of breast cancer.
2. Does having PASH increase my risk of getting cancer later? No. Research indicates that PASH does not increase your long-term risk of developing breast cancer [1].
3. Can men get PASH? Yes, though it is rare. It typically occurs in men who also have gynecomastia (enlarged breast tissue) [1].
4. How is PASH usually found? Most cases are found incidentally during routine mammograms or during a biopsy for another breast concern [1].
5. What is the main cause of PASH? The exact cause is unknown, but it is strongly linked to high levels of the hormones estrogen and progesterone.
6. Is surgery always necessary for PASH? No. If the growth is small and not causing symptoms, your doctor may recommend just watching it with yearly mammograms [1].
7. What is a core needle biopsy? A core needle biopsy is a procedure where a hollow needle is used to take a small tissue sample from the breast for testing [1].
8. Can PASH cause pain? While often painless, PASH can cause breast enlargement or lumps that may be uncomfortable for some individuals.
9. Will PASH go away on its own? PASH typically does not disappear on its own and may require monitoring or removal if it grows.
10. What does "pseudoangiomatous" mean? The term "pseudoangiomatous" refers to the microscopic appearance of the tissue, which looks like blood vessels but is actually just spaces in the stromal tissue.
11. Can PASH come back after surgery? Yes, there is a chance the growth can recur, which is why regular follow-up imaging is recommended after surgery [1].
12. Does PASH affect both breasts? PASH can occur in one breast (unilateral) or both breasts (bilateral) [1].
13. Are there medications to treat PASH? Currently, there are no specific medications to cure PASH; treatment focuses on monitoring or surgery.
14. Should I be worried if I feel a lump? Any new breast lump should be evaluated by a healthcare provider, but many lumps, including PASH, are benign.
15. How often should I have a mammogram if I have PASH? Your doctor will likely recommend at least an annual mammogram to monitor the growth or check for new changes.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Source date: August 12, 2025.
Related Reading
What Is Benign Breast Disease? Types, Symptoms, and Treatment explains noncancerous breast changes, the group that includes PASH.
Core Needle Breast Biopsy: Procedure, Recovery and Results describes the needle biopsy most often used to confirm PASH.
Mammogram: Types, How to Prepare, What Happens and Your Results explains the breast X-ray that may first show a PASH lump.
Breast Ultrasound: Why It's Done, What to Expect and Results describes the imaging test used to look closely at breast lumps.
References
Cleveland Clinic. PASH (Pseudoangiomatous Stromal Hyperplasia). Cleveland Clinic. August 12, 2025. https://my.clevelandclinic.org/health/diseases/pash-pseudoangiomatous-stromal-hyperplasia
Koshy R, et al. Characterizing pseudoangiomatous stromal hyperplasia (PASH) of the breast. Histopathology. 2026;89(1):174-180. PMID 41731999. https://doi.org/10.1111/his.70127
Li H, et al. Analysis of Conventional Ultrasound and Contrast-Enhanced Ultrasound Features of Pseudoangiomatous Stromal Hyperplasia. Breast J. 2025;2025:6070736. PMID 40687941. https://doi.org/10.1155/tbj/6070736




Comments